End-stage renal disease reduces the expression of drug-metabolizing cytochrome P450s

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2299-5684

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: End-stage renal disease reduces the expression of drug-metabolizing cytochrome P450s ; volume:72 ; number:6 ; day:8 ; month:7 ; year:2020 ; pages:1695-1705 ; date:12.2020
Pharmacological reports ; 72, Heft 6 (8.7.2020), 1695-1705, 12.2020

Creator: Déri, Máté Tamás
Kiss, Ádám Ferenc
Tóth, Katalin
Paulik, József
Sárváry, Enikő
Kóbori, László
Monostory, Katalin

Contributor: SpringerLink (Online service)

DOI: 10.1007/s43440-020-00127-w

URN: urn:nbn:de:101:1-2021010907274460609594

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:25 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Déri, Máté Tamás
Kiss, Ádám Ferenc
Tóth, Katalin
Paulik, József
Sárváry, Enikő
Kóbori, László
Monostory, Katalin
SpringerLink (Online service)

Other Objects (12)

Prediction of cytochrome P450 isoform responsible for metabolizing a drug molecule

Phenotypic Models of Drug-Drug-Gene Interactions Mediated by Cytochrome Drug-Metabolizing Enzymes

Levomepromazine and clozapine induce the main human cytochrome P450 drug metabolizing enzyme CYP3A4

Palliative rehabilitation in end-stage renal failure

Transposable elements are enriched within or in close proximity to xenobiotic-metabolizing cytochrome P450 genes

Renal Denervation in End-Stage Renal Disease: Current Evidence and Perspectives

Effects of marine biotoxins on drug-metabolizing cytochrome P450 enzymes and their regulation in mammalian cells

Investigations on hepatic and intestinal drug-metabolizing cytochrome P450 enzymes in wild boar compared to domestic swine

High prevalence of frailty in end-stage renal disease

Arterial structure and function in end-stage renal disease

The genetic landscape of major drug metabolizing cytochrome P450 genes—an updated analysis of population-scale sequencing data

Genomic Damage in Endstage Renal Disease - Contribution of Uremic Toxins

Prediction of cytochrome P450 isoform responsible for metabolizing a drug molecule

Phenotypic Models of Drug-Drug-Gene Interactions Mediated by Cytochrome Drug-Metabolizing Enzymes

Levomepromazine and clozapine induce the main human cytochrome P450 drug metabolizing enzyme CYP3A4

Palliative rehabilitation in end-stage renal failure

Transposable elements are enriched within or in close proximity to xenobiotic-metabolizing cytochrome P450 genes

Renal Denervation in End-Stage Renal Disease: Current Evidence and Perspectives

Effects of marine biotoxins on drug-metabolizing cytochrome P450 enzymes and their regulation in mammalian cells

Investigations on hepatic and intestinal drug-metabolizing cytochrome P450 enzymes in wild boar compared to domestic swine

High prevalence of frailty in end-stage renal disease

Arterial structure and function in end-stage renal disease

The genetic landscape of major drug metabolizing cytochrome P450 genes—an updated analysis of population-scale sequencing data

Genomic Damage in Endstage Renal Disease - Contribution of Uremic Toxins

Prediction of cytochrome P450 isoform responsible for metabolizing a drug molecule

Phenotypic Models of Drug-Drug-Gene Interactions Mediated by Cytochrome Drug-Metabolizing Enzymes

Levomepromazine and clozapine induce the main human cytochrome P450 drug metabolizing enzyme CYP3A4

Palliative rehabilitation in end-stage renal failure

Transposable elements are enriched within or in close proximity to xenobiotic-metabolizing cytochrome P450 genes

Renal Denervation in End-Stage Renal Disease: Current Evidence and Perspectives

Effects of marine biotoxins on drug-metabolizing cytochrome P450 enzymes and their regulation in mammalian cells

Investigations on hepatic and intestinal drug-metabolizing cytochrome P450 enzymes in wild boar compared to domestic swine

High prevalence of frailty in end-stage renal disease

Arterial structure and function in end-stage renal disease

The genetic landscape of major drug metabolizing cytochrome P450 genes—an updated analysis of population-scale sequencing data

Genomic Damage in Endstage Renal Disease - Contribution of Uremic Toxins

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

End-stage renal disease reduces the expression of drug-metabolizing cytochrome P450s

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Prediction of cytochrome P450 isoform responsible for metabolizing a drug molecule

Phenotypic Models of Drug-Drug-Gene Interactions Mediated by Cytochrome Drug-Metabolizing Enzymes

Levomepromazine and clozapine induce the main human cytochrome P450 drug metabolizing enzyme CYP3A4

Palliative rehabilitation in end-stage renal failure

Transposable elements are enriched within or in close proximity to xenobiotic-metabolizing cytochrome P450 genes

Renal Denervation in End-Stage Renal Disease: Current Evidence and Perspectives

Effects of marine biotoxins on drug-metabolizing cytochrome P450 enzymes and their regulation in mammalian cells

Investigations on hepatic and intestinal drug-metabolizing cytochrome P450 enzymes in wild boar compared to domestic swine

High prevalence of frailty in end-stage renal disease

Arterial structure and function in end-stage renal disease

The genetic landscape of major drug metabolizing cytochrome P450 genes—an updated analysis of population-scale sequencing data

Genomic Damage in Endstage Renal Disease - Contribution of Uremic Toxins

Prediction of cytochrome P450 isoform responsible for metabolizing a drug molecule

Phenotypic Models of Drug-Drug-Gene Interactions Mediated by Cytochrome Drug-Metabolizing Enzymes

Levomepromazine and clozapine induce the main human cytochrome P450 drug metabolizing enzyme CYP3A4

Palliative rehabilitation in end-stage renal failure

Transposable elements are enriched within or in close proximity to xenobiotic-metabolizing cytochrome P450 genes

Renal Denervation in End-Stage Renal Disease: Current Evidence and Perspectives

Effects of marine biotoxins on drug-metabolizing cytochrome P450 enzymes and their regulation in mammalian cells

Investigations on hepatic and intestinal drug-metabolizing cytochrome P450 enzymes in wild boar compared to domestic swine

High prevalence of frailty in end-stage renal disease

Arterial structure and function in end-stage renal disease

The genetic landscape of major drug metabolizing cytochrome P450 genes—an updated analysis of population-scale sequencing data

Genomic Damage in Endstage Renal Disease - Contribution of Uremic Toxins

Prediction of cytochrome P450 isoform responsible for metabolizing a drug molecule

Phenotypic Models of Drug-Drug-Gene Interactions Mediated by Cytochrome Drug-Metabolizing Enzymes

Levomepromazine and clozapine induce the main human cytochrome P450 drug metabolizing enzyme CYP3A4

Palliative rehabilitation in end-stage renal failure

Transposable elements are enriched within or in close proximity to xenobiotic-metabolizing cytochrome P450 genes

Renal Denervation in End-Stage Renal Disease: Current Evidence and Perspectives

Effects of marine biotoxins on drug-metabolizing cytochrome P450 enzymes and their regulation in mammalian cells

Investigations on hepatic and intestinal drug-metabolizing cytochrome P450 enzymes in wild boar compared to domestic swine

High prevalence of frailty in end-stage renal disease

Arterial structure and function in end-stage renal disease

The genetic landscape of major drug metabolizing cytochrome P450 genes—an updated analysis of population-scale sequencing data

Genomic Damage in Endstage Renal Disease - Contribution of Uremic Toxins

Related objects

Reset password